Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2105 · · 10 pages · English
Summary by 6ix AI
The report confirms the total authorized share capital and provides details on issued shares and treasury shares. It also includes a public float sufficiency confirmation, indicating compliance with applicable requirements. The filing notes an increase in issued shares during the month and confirms that all necessary authorizations were obtained.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Laekna
- Interim Report 2026
- New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
- ADA 2025 | Laekna Presented Clinical and Pre-clinical Studies Results of LAE102, LAE103 and LAE123
- Laekna Announces IND Approval of LAE120 (a Novel USP1 Inhibitor) for Treatment of Advanced Solid Tumors by FDA
- Laekna Announces Poster Presentation on Internally Discovered Selective PI3Kα Inhibitor at SABCS 2024
Later from Laekna
All Laekna news releasesFollow Laekna into a list and get an email when it puts out news.
Follow Laekna